Konno, Y., Kimura, I., Uriu, K., Fukushi, M., Irie, T., Koyanagi, Y., Sauter, D., Gifford, R., USFQ-COVID19 Consortium, Nakagawa, S. & Sato, K. 2020, 'SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant', Cell Reports, 32(12), article no: 108185. http://dx.doi.org/10.1016/j.celrep.2020.108185